Hospital Slams Bids To Ax $10M Pepcid Patent Verdict

Law360, New York (February 16, 2017, 4:34 PM EST) -- A Boston hospital argued Wednesday that attempts by over-the-counter drug maker Perrigo Co. to overturn a $10.2 million Pepcid patent infringement verdict ignored the evidence presented to the jury.

The drugmaker’s multiple motions for overrulings of the verdict, for new trials to overturn the finding that Perrigo infringed Brigham and Women’s Hospital Inc. now-expired patent for the Pepcid Complete antacid, or to shrink the hospital's award pass over the evidence and present already-rejected defenses, the hospital told a Massachusetts federal court.

“Rather than presenting a single,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.